Kobayashi Pharmaceutical Co., Ltd.

KBYPF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$306$56,288$52,405$50,873
Short-Term Investments$86$13,386$14,874$14,872
Receivables$272$32,973$32,575$49,442
Inventory$207$30,653$27,390$24,163
Other Curr. Assets$21$2,671$5,088$5,118
Total Curr. Assets$893$135,971$132,332$144,468
Property Plant & Equip (Net)$505$73,447$67,666$67,448
Goodwill$52$7,805$8,406$9,260
Intangibles$67$10,056$10,643$11,414
Long-Term Investments$214$28,669$27,972$9,745
Tax Assets$22$3,449$0$3,087
Other NC Assets$14$1,309$4,733$19,943
Total NC Assets$875$124,735$119,420$120,897
Other Assets$0$4$0$3
Total Assets$1,767$260,710$251,752$265,368
Liabilities
Payables$102$9,103$15,148$8,264
Short-Term Debt$2$357$363$343
Tax Payable$0$2,617$0$2,259
Deferred Revenue$0$0$0$0
Other Curr. Liab.$182$34,428$24,173$35,557
Total Curr. Liab.$286$46,505$39,684$46,423
LT Debt$2$394$426$503
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$21$1,988$0$1,554
Other NC Liab.$24$3,582$4,586$3,418
Total NC Liab.$48$5,964$5,012$5,475
Other Liabilities$0$0$0$0
Cap. Leases$2$749$789$846
Total Liabilities$334$52,469$44,696$51,898
Equity
Pref Stock$0$0$0$0
Common Stock$23$3,450$3,450$3,450
Retained Earnings$1,402$207,022$205,479$208,240
AOCI$172$22,014$22,370$26,021
Other Equity-$164-$24,245-$24,245-$24,245
Total Equity$1,433$208,241$207,054$213,466
Supplemental Information
Minority Interest$0$0$2$4
Total Liab. & Tot. Equity$1,767$260,710$251,752$265,368
Net Debt-$301-$55,537-$51,616-$50,027